Current Issue

Jul 02, 2016
BioPharm International
CDMOs need to be aware that unfavorable public markets put emerging bio/pharma R&D spending at risk in 2017.
Jul 02, 2016
BioPharm International
Agency guidance and industry standards aim to reduce lapses and improve quality operations.
Jul 01, 2016
BioPharm International
The author addresses critical issues to consider prior to performing forced degradation studies and provides best practice recommendations for these types of studies.
Jul 01, 2016
BioPharm International
CPhI Pharma Awards seek nominations for excellence in biopharma development and manufacturing.
Jul 01, 2016
BioPharm International
Pressures to accelerate current and next-gen therapies are challenging traditional microbiological testing methods.
Jul 01, 2016
BioPharm International
A streamlined approach may enhance process efficiency and product quality.
Jul 01, 2016
BioPharm International
Capacity for complex therapeutics is becoming increasingly difficult to predict.
Jul 01, 2016
BioPharm International
The author provides a review of the concepts of design and qualification that apply to single-use systems.
Jul 01, 2016
BioPharm International
Recent trends in raw materials packaging may impact manufacturing, quality, and cost of biopharmaceuticals.
Jul 01, 2016
BioPharm International
The authors present an overview of the types of RNA-based therapeutics in existence and their optimal methods of manufacture, purification, formulation, and delivery.
lorem ipsum